000 01163nam a2200337Ia 4500
001 15388
003 BIBL
005 20160527200144.0
008 840206s1984 dcua b f00100 eng d
010 _a84601000
020 _c20.00
035 _a(OCoLC)10380434
037 _a052-003-00939-1
_bGPO
040 _aKSG
_cKSG
_dGPO
049 _aEVLg
_b338.476606
_bC734
_cc1
074 _a1070-M
086 0 _aY 3.T 22/2:2 C 73/7
088 _aOTA-BA-218
092 _a338.476606
_bC734
099 _aY 3.T 22/2:2 C 73/7
245 0 0 _aCommercial biotechnology
_ban international assessment.
260 0 _aWashington, D.C.
_bCongress of the U.S., Office of Technology Assessment
_bFor sale by the Supt. of Docs., U.S. G.P.O.
_c1984.
300 _avii, 612 p.
_bill.
_c26 cm.
500 _a"January 1984"--P. [4] of cover.
500 _a"OTA-BA-218"--P. [4] of cover.
504 _aIncludes bibliographies and index.
650 0 _aBionics.
_2Local
_962490
650 0 _aBiology, Experimental
_xEconomic aspects.
_2Local
_962468
650 0 _aRecombinant DNA
_2Local
_9157517
710 1 0 _aUnited States
_bCongress.
_bOffice of Technology Assessment.
_2Local
_9182913
999 _c11299
_d11299